Abstract:Cerebral ischemia (stroke) triggers a complex series of biochemical and molecular mechanisms that impairs the neurologic functions through breakdown of cellular integrity mediated by excitotoxic glutamatergic signalling, ionic imbalance, free-radical reactions, etc. These intricate processes lead to activation of signalling mechanisms involving calcium/calmodulin-dependent kinases (CaMKs) and mitogen-activated protein kinases (MAPKs) such as extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). The distribution of these transducers bring them in contact with appropriate molecular targets leading to altered gene expression, e.g. ERK and JNK mediated early gene induction, responsible for activation of cell survival/damaging mechanisms. Moreover, inflammatory reactions initiated at the neurovascular interface and alterations in the dynamic communication between the endothelial cells, astrocytes and neurons are thought to substantially contribute to the pathogenesis of the disease. The damaging mechanisms may proceed through rapid nonspecific cell lysis (necrosis) or by active form of cell demise (apoptosis or necroptosis), depending upon the severity and duration of the ischemic insult. A systematic understanding of these molecular mechanisms with prospect of modulating the chain of events leading to cellular survival/damage may help to generate the potential strategies for neuroprotection. This review briefly covers the current status on the molecular mechanisms of stroke pathophysiology with an endeavour to identify potential molecular targets such as targeting postsynaptic density-95 (PSD-95)/N-methyl-d-aspartate (NMDA) receptor interaction, certain key proteins involved in oxidative stress, CaMKs and MAPKs (ERK, p38 and JNK) signalling, inflammation (cytokines, adhesion molecules, etc.) and cell death pathways (caspases, Bcl-2 family proteins, poly (ADP-ribose) polymerase-1 (PARP-1), apoptosis-inducing factor (AIF), inhibitors of apoptosis proteins (IAPs), heat shock protein 70 (HSP70), receptor interacting protein (RIP), etc., besides targeting directly the genes itself. However, selecting promising targets from various signalling cascades, for drug discovery and development is very challenging, nevertheless such novel approaches may lead to the emergence of new avenues for therapeutic intervention in cerebral ischemia.

Background and Therapeutic Approaches

Signaling Pathways in Brain Ischemia: Mechanisms and Therapeutic Implications.

Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches

Micrornas: Innovative Targets for Cerebral Ischemia and Stroke

Molecular Mechanisms of Ischemic Stroke: A Review Integrating Clinical Imaging and Therapeutic Perspectives

The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets

Stroke: Molecular mechanisms and therapies: Update on recent developments

Unveiling the Regulatory Role of miRNAs in Stroke Pathophysiology and Diagnosis

Ischemic Stroke: Pathophysiology and Evolving Treatment Approaches

miRNAs as modulators of neuroinflammation and excitotoxicity: Implications for stroke therapeutics

Emerging Role of microRNAs in Cerebral Stroke Pathophysiology

Molecular targets in cerebral ischemia for developing novel therapeutics

Non-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death

Insight into the pathophysiological advances and molecular mechanisms underlying cerebral stroke: current status

Mechanisms of ischemic brain injury

Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis

A Novel Perspective on Ischemic Stroke: A Review of Exosome and Noncoding RNA Studies

Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives

Inflammatory mechanisms in ischemic stroke: therapeutic approaches